cfr_sections: 21:21:1.0.1.1.22.3.98.1
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| section_id | title_number | title_name | chapter | subchapter | part_number | part_name | subpart | subpart_name | section_number | section_heading | agency | authority | source_citation | amendment_citations | full_text |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21:21:1.0.1.1.22.3.98.1 | 21 | Food and Drugs | I | A | 58 | PART 58—GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES | C | Subpart C—Facilities | 58.41 | § 58.41 General. | FDA | 21 U.S.C. 342, 346, 346a, 348, 351, 352, 353, 355, 360, 360b-360f, 360h-360j, 371, 379e, 381; 42 U.S.C. 216, 262, 263b-263n. | 43 FR 60013, Dec. 22, 1978, unless otherwise noted. | [52 FR 33780, Sept. 4, 1987] | Each testing facility shall be of suitable size and construction to facilitate the proper conduct of nonclinical laboratory studies. It shall be designed so that there is a degree of separation that will prevent any function or activity from having an adverse effect on the study. |